Effects of Recombinant Cholera Toxin B Subunit (rCTB) on Cellular Immune Responses: Enhancement of Delayed‐Type Hypersensitivity Following Intranasal Co‐Administration of Mycobacterium bovis‐BCG with rCTB
Effects of Recombinant Cholera Toxin B Subunit (rCTB) on Cellular Immune Responses: Enhancement of Delayed‐Type Hypersensitivity Following Intranasal Co‐Administration of Mycobacterium bovis‐BCG with rCTB
复制标题
重组霍乱毒素 B 亚基 (rCTB) 对细胞免疫反应的影响:牛分枝杆菌-BCG 与 rCTB 鼻内联合给药后迟发型超敏反应增强
DOI:
10.1111/j.1348-0421.2004.tb03536.x
复制
发表时间:
2004
影响因子:
2.6
通讯作者:
N. Goto
中科院分区:
文献类型:
--
作者:
J. Maeyama;M. Isaka;Y. Yasuda;K. Matano;K. Morokuma;K. Ohkuma;K. Tochikubo;Saburo Yamamoto;N. Goto
Recombinant cholera toxin B subunit (rCTB) is a safe and potent mucosal adjuvant. To gain insight into the mechanism underlying the adjuvant effect of rCTB, the effects of rCTB on cell‐mediated immune responses of mice and guinea pigs were examined after intranasal administration of Mycobacterium bovis‐bacillus Calmette‐Guérin (BCG) with and without rCTB. Delayed‐type hypersensitivity, for skin reactions in guinea pigs and for footpad swelling reactions in mice, to purified protein derivative (PPD) were enhanced by intranasal co‐administration of BCG and rCTB, as compared to giving BCG alone to these animals. Moreover, tumor necrosis factor (TNF)‐α and interferon (IFN)‐γ production of spleen cells and antigen specific spleen cell proliferation, stimulated with PPD, were enhanced in the presence of rCTB. These results strongly suggest that rCTB enhances cellular as well as humoral immune responses.
DOI:
--
发表时间:
1984
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Elson,CO;Ealding,W
通讯作者:
Ealding,W